-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-appendix-c.xlsx
January 01, 2024 - List of Evidence Tables
Category Evidence table
Systematic Reviews Evidence Table C-1. Characteristics and findings of included systematic reviews
Primary studies: Study characteristics Evidence Table C-2. Study characteristics of included primary studies
Evidence Table C-3. Intervention characteristics of include…
-
effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
December 01, 2013 - Fidaxomicin shows early superiority over
vancomycin on intention-to-treat analyses of
pivotal randomized
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
March 15, 2016 - perplexing that the authors don’t appear to
support a treat-to-target threshold, yet cite data from analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
January 01, 2012 - Fidaxomicin shows early superiority over
vancomycin on intention-to-treat analyses of
pivotal randomized
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
January 01, 2016 - to the manufacturer, the
NDA addresses questions raised in the FDA letter and provides additional analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_appendixes.pdf
May 23, 2005 - Practice guidelines[mh]
“Practice parameter”
Standard*[ti]
Standards[sh]
“White paper”
Meta-analyses